NFKB1 and Myocardial fibrosis: In this study, we demonstrated that DEL‐1 could alleviate myocardial fibrosis, inflammation, and cardiomyocyte apoptosis in MI in vitro and in vivo via regulating the Sirt1/NF‐κB signaling pathway.